Journal of Cancer Treatment and Research

Special Issue

Cancer and Inflammation

  • Submission Deadline: 30 April 2015
  • Status: Submission Closed
  • Lead Guest Editor: Mükerrem Betül Yerer-Aycan
About This Special Issue
The link between inflammation and cancer has been suggested by epidemiological and experimental data and confirmed by anti-inflammatory therapies that show efficacy in cancer prevention and treatment. The fact that continuous irritation over long periods of time can lead to cancer had already been described in the traditional Ayurvedic (meaning “the science of long life”) medical system, written as far back as 5000 years ago. Whether this irritation is the same as what Rudolf Virchow referred to as inflammation in the 19th century is uncertain. Virchow first noted that inflammatory cells are present within tumors and that tumors arise at sites of chronic inflammation. This inflammation is now regarded as a “secret killer” for diseases such as cancer. For example, inflammatory bowel diseases such as Crohn disease and ulcerative colitis are associated with increased risk of colon adenocarcinoma, and chronic pancreatitis is related to an increased rate of pancreatic cancer. Taking into account the high relationship between cancer and inflammation it seems to be a necessity to gather this knowledge in a special issue, namely Cancer and Inflammation.
Lead Guest Editor
  • Mükerrem Betül Yerer-Aycan

    Department of Pharmacology,Faculty of Pharmacy,University of Erciyes, Kayseri, Turkey

Guest Editors
  • Ram Prasad

    University of Alabama at Birmingham, United States

  • Ram Prasad

    University of Alabama at Birmingham, United States

  • xiang cheng

    Department of Radiation Oncology, Ohio State University, Columbus, United States

  • Gautam Bedadala

    Bayer, United States

  • Rajasekharreddy Pala

    Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Irvine, United States

  • Maheedhar Kodali

    Iinstitute of Regenerative Medicine, Texas A&M Health Science Center, College of Medicine, United States

  • Venkatesh Kota

    Department of Biochemistry and Molecular Biology, Medical University of South Carolina, United States

  • Maheedhar Kodali

    Iinstitute of Regenerative Medicine, Texas A&M Health Science Center, College of Medicine, United States

  • Shuli Liu

    Department of Oral and Maxillofacial–Head and Neck Oncology, Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, China

  • Shuli Liu

    Department of Oral and Maxillofacial–Head and Neck Oncology, Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, China

  • Yingqiu Xie

    Department of Biology, Nazarbayev University School of Science and Technology, Kazakhstan

  • Iana Katz

    Department of Immunology, Pasteur Institute, São Paulo, Brazil

  • Sercan Ergün

    Department of Medical Biology, Faculty of Medicine, Gaziantep University, Sahinbey, Turkey

  • Ahmed Ragab Ali Mourad

    Urology Department, Zagazig University, Zagazig, Egypt

  • zhang nan

    ,Urology,The people's hospital of Zhengzhou ,, China

  • Rana Saif

    Zhejiang University College of Medicine, Zhejiang University, Hangzhou, China, Hangzhou, China

  • Assia BENSALEM

    Medical Oncology department, Etablissement Hospitalier Didouche Mourad, faculte de medecine 3, Constantine, Algeria

  • Jalal-Eddeen Saleh

    EPI Unit, World Health Organization, Jimeta-Yola, Nigeria

  • Nina Gridina

    A.P.Romodanov Institute of neurosurgery, lab. of experimental neurosurgery, Ukraine

  • Rasoul Rajaei

    Laboratory of Systems Biology and Bioinformatics (LBB), Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran